Friday, 19 May 2023

Evaluation of Hematological Changes in Donors Post Apheresis: An Institutional Study | Chapter 11 | New Advances in Medicine and Medical Science Vol. 1

 The aim of the study search out evaluate the haematological changes that occured post plateletpheresis in apheresis donor and compare pre and postdonation haematological changes in benefactors and to determine the results of apheresis, plateletpheresis on donor’s health. The output, quality of platelet apheresis group has improved by way of the considerable advancement in the robotic cell separators.This is an practical cross-sectional study exhausted laboratory at RL Jalappa Blood Bank, Tamaka, Kolar, Karnataka, India. The study was done from March 2019 to August 2020. A total of 300 active donors (plateletpheresis backers) were included in the study. All donors seen plateletpheresis (Haemonetics MCS), and pre- and post-donation haematological limits including haemoglobin aggregation, haematocrit (Hct), platelet, white, and red blood cell counts were computed. Postdonation haematological limits such as platelet count, haemoglobin, haematocrit, White Blood Cells (WBC), Red Blood Cells (RBC) counts of the contributor was noted and it was compared accompanying pre-donation haematological limits. Statistical analysis was proficient utilising statistical software SPSS form 16.0. Platelet count, haemoglobin, WBC count, RBC count and haematocrit were noted lower 262 donors and considerably significant reduction was noticed in these parameters postdonation. Donor limit platelet count (lac/mL) value was reduced from 273.57- 224.28 inasmuch as WBC count (cu/mm) predonation value declined from 9.91-8.86 Postdonation, haemoglobin (g/dL) value declined from 14.46-12.91, haematocrit (%) decreased slightly from 45.19- 44.19, RBC count (heap/mm3) decreased from 5.21-5.01. So it is decided that values were dropped off postdonation. Platelets transfusion can be finished either for a remedial or protective cause. Most of the transfusions are given to prevent bleeding in thrombocytopenic subjects.Current research carried out explained SDP is efficacious in of thrombocytopenia healing and it is safe from recipient’s perspective. Technical cadre training, processes carried out under the supervision of transference medicine consultants, and close monitoring of these benefactors are required to prevent unfavorable events for the backers' well-being.

Author(s) Details:

Subhashis Das,
Department of Pathology, Sri Devaraj Urs Academy of Higher Education and Research (SDUAHER), Tamaka, Kolar, Karnataka, India.

Nikhil,
Department of Pathology, Sri Devaraj Urs Academy of Higher Education and Research (SDUAHER), Tamaka, Kolar, Karnataka, India.

Gaurav Khichariya,
Gaurav Khichariya

T. Amrutha,
Department of Pathology, Sri Devaraj Urs Academy of Higher Education and Research (SDUAHER), Tamaka, Kolar, Karnataka, India.

Snigdha Sinha,
Department of Pathology, Sri Devaraj Urs Academy of Higher Education and Research (SDUAHER), Tamaka, Kolar, Karnataka, India.

Please see the link here: https://stm.bookpi.org/NAMMS-V1/article/view/10564

No comments:

Post a Comment